Page 27 - Delaware Medical Journal - November/December 2019

PUBLIC HEALTH
lifestyle changes (particularly smoking cessation) and diligence in the taking of medications.
Despite some hesitancy on the part of some physicians to fully embrace lung cancer screening and despite overdiagnosis and incidentalomas, Dr. Rattay’s article shows Bob Frelick’s quest to diagnose lung cancer in its early stage and to improve survival statistics in Delaware. He would have applauded her accomplishment and I’m sure he would have sent a congratulatory note.
AUTHOR’S NOTE
Many thanks to the interventional cardiologist James A. Lally, MD for the detailed information about coronary artery calcification screening and scoring.
CONTRIBUTING AUTHORS
JAMES F. LALLY, MD is a retired radiologist and a member of the Medical Society of Delaware Editorial Board. In the early 2000s, he was the principal radiologist in the Helen F. Graham Cancer Center’s early lung-cancer screening program.
REFERENCES
1. Lally JF. Screening for lung cancer. Del Med J. 1993 65(4): 273-274.
2. Henschke CI, McCauley DI, Yankelevitz DF, et al. Early lung cancer action project. Lancet. 1999 354:99-105.
3. The National Lung Screening Trial Research Team. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Eng J Med. 2011 365:395-409.
4. Rattay KT. Early lung cancer screening in Delaware. Del Med J. 2019 91(5): 210-217.
5. Welch HG, Black WC. Overdiagnosis in cancer. Journal of the National Cancer Institute. 2010 102(9): 605-613.
6. Sox HC. Better evidence about screening for lung cancer. N Eng J Med. 2011
365:455-457.
7. Kobayashi Y, Mitsudomi T. Management of ground-glass opacities: should all pulmonary lesions with ground-glass opacity be resected? Transl Lung Cancer Res. 2013 2(5): 354-363.
8. Kucharcyk M, Mendes RJ, McGregor A, et al. Assessing the impact of incidental findings in a lung cancer screening study by using low-dose computed tomography. Canadian Association of Radiologists Journal. 2011 62(2): 141-145.
9. Chiles C, Duan F, Ravenal JG et al. Association of coronary artery calcium and mortality in the National Lung Screening Trial: A comparison of three scoring methods. Radiology. 2015 276(1): 82-90.
10. Bonow RO. Should coronary calcium screening be used in cardiovascular prevention strategies? N Eng J Med. 2009 361: 990-997.
11. Grayburn PA. Interpreting the coronary- artery calcium score. N Eng J Med. 2012 366: 294-296.
12. Polonsky TS, Greenland P. Viewing the value of coronary artery calcium testing from different perspectives. JAMA Cardiology. 2018 3(10):908-910.

MSDIS Congratulates Delaware’s Top Physicians